ARCHIVES

Aphton To Test Anti-Gastrin Drug At M. D. Anderson. NAS

This article is from The Cancer Letter archive.

Vol. 26 No. 13 | March 31, 2000

Download PDF Visit The Full Archive

Related Articles

No Recision Seen, New Money To Low In Mid-March

February 20, 1976

Avastin Phase III Trial Meets Endpoint: PFS in Platinum-Sensitive Ovarian Cancer

February 25, 2011

ACS Says NCI Needs $1.1 Billion, Cites Progress In Prevention, Control

April 29, 1977

Five Center Core Grants Renewed

February 2, 1979

Breast Cancer Survivors Report More Severe Fatigue Than Healthy Women

September 28, 2007

What? Only a “B”? NLST Co-Principal Investigator Begs to Differ with USPSTF Lung Cancer Screening Grade

August 9, 2013